Adli AbdAllah Selim

Scopus Publications

Design, eco-friendly synthesis, antibacterial evaluation, radiolabeling and biodistribution study of some novel enaminonitrile pyridine derivatives
Kurls E. Anwer, Gamal Abdelaziz, Basma M. Essa, Adli A. Selim, Amira A. El‐Sayed, et al.
Applied Radiation and Isotopes, 2026
Ecofriendly Synthesis of New Azo Compounds as Antibacterial Agents: In Vitro Screening and Preliminary In Vivo Evaluation Using 131I-Radiolabeling
Kurls E. Anwer, Basma M. Essa, Adli A. Selim, Galal H. Sayed, Safaa S. Shaban
Archiv Der Pharmazie, 2026
This work is designed to establish sustainable routes for the synthesis of new variable azo heterocyclic derivatives via the reaction of 2‐[(dicyanomethyl)diazinyl]benzoic acid 2 with different nucleophilic agents, including hydrazine derivatives (such as phenyl hydrazine and 2,4‐dinitrophenylhydrazine), acylhydrazines (e.g., benzoylhydrazine), nitrogen‐based nucleophiles (semicarbazide and thiosemicarbazide), oxygen‐containing reagents (hydroxylamine), as well as urea, thiourea, guanidine hydrochloride, and o ‐phenylenediamine. Both conventional heating and microwave approaches were used to furnish the desired heterocycles. The compounds exhibited potent antibacterial activity against Gram‐positive and Gram‐negative pathogens, outperforming fluconazole. The lead compound was successfully radiolabeled with 131 I in high yield (87.72% RCY). In vivo evaluation in an infection model demonstrated excellent pharmacokinetics, with specific uptake in infected tissue (13.7% ID/g at 1 h) and a high target‐to‐non‐target ratio (6.31). These findings underscore the theranostic potential of these azo compounds, positioning them as both antimicrobial agents and candidate radiotherapeutics for infection.
Innovative hybrid 99mTc-exemestane magnesium nanoparticles: Pioneering dual-mode theranostic and precision tumor targeting
Adli A. Selim, Mohamed A. Amin, Mahmoud M. Abouhashim, Ahmed B. Ibrahim
Journal of Drug Delivery Science and Technology, 2026
99mTc-labeled benzenesulfonamide derivative-entrapped gold citrate nanoparticles as an auspicious tumour targeting
Adli A. Selim, Tamer M. Sakr, Basma M. Essa, Galal H. Sayed, Kurls E. Anwer
Scientific Reports, 2025
Sulfonamide derivatives are a significant class of medicinal compounds. Gold nanoparticles (AuNPs) offer precise cancer treatment through targeted delivery, boasting high drug-loading capacity and low toxicity. This study aimed to develop and evaluate 99mTc-labeled benzenesulfonamide derivative-entrapped gold citrate nanoparticles as a tumor-targeting agent. A novel benzenesulfonamide derivative bearing a pyridine moiety was synthesized. Compound 3 (4-((3-cyano-4-(2,4-dichlorophenyl)-6-phenylpyridin-2-yl)amino)-N-(diaminomethylene)benzenesulfonamide) exhibited remarkable anti-cancer activity against MCF-7 cells. The chemical reduction method was employed to create compound 3-citrate-AuNPs. A comprehensive examination of the synthesized nano-platform was conducted, including zeta potential, size analysis, radiochemical yield, and in-vivo biodistribution in tumor-bearing mice. The nano-platform was successfully produced with good stability, optimal particle size (9 nm diameter for AuNPs), and high radiochemical purity for [99mTc]Tc-compound 3 (88.31 ± 2.14%). In-vivo investigations revealed that intravenously administered [99mTc]Tc-compound 3-citrate-AuNPs accumulated in tumors with a high target-to-non-target ratio. The findings validate the efficacy of the novel [99mTc]Tc-compound 3-citrate-AuNPs platform as a tumor-targeting agent.
Actinium-225/Bismuth-213 as Potential Leaders for Targeted Alpha Therapy: Current Supply, Application Barriers, and Future Prospects
Mohamed F. Nawar, Adli A. Selim, Basma M. Essa, Alaa F. El-Daoushy, Mohamed M. Swidan, et al.
Cancers, 2025
Alpha therapy (TAT) relies on combining alpha-emitting radionuclides with specific cell-targeting vectors to deliver a high payload of cytotoxic radiation capable of destroying tumor tissues. TAT efficacy comes from the tissue selectivity of the targeting vector, the high linear energy transfer (LET) of the radionuclide, and the short range of alpha particles in tissues. Recent research studies have been directed to evaluate TAT on a preclinical and clinical scale, including evaluating damage to tumor tissues with minimal toxic radiation effects on surrounding healthy tissues. This review highlights the use of Actinium-225/Bismuth-213 radionuclides as promising candidates for TAT. Herein, we begin with a discussion on the production and supply of [225Ac]Ac/[213Bi]Bi followed by the formulation of [225Ac]Ac/[213Bi]Bi-radiopharmaceuticals using different radiolabeling techniques. Finally, we have summarized the preclinical and clinical evaluation of these potential radiotheranostic agents.
Synthesis and radiolabelled evaluation of novel pyrimidine derivatives as dual α-amylase inhibitors and GIT-targeted molecular imaging probe
Doaa A. Elsayed, Wael Shehta, S. El-Kalyoubi, Adli Selim, Mohammed G. Assy, et al.
Rsc Advances, 2025
An 131I-labeled α-amylase inhibitor shows exceptional stomach retention (59.6% ID per g) and sustained intestinal uptake, highlighting its promise as a GI-targeted antidiabetic agent and potential GI imaging probe.
Silybin loaded Ag-nanoparticles as a drug delivery system for solid tumor theragnosis: Extraction, radioiodination, and biodistribution study
Basma M. Essa, Islam M. Abdelmonem, Mohamed A. Amin, Adli A. Selim
Archiv Der Pharmazie, 2025
Biocompatible silver nanoparticles (AgNPs) are employed with an active ingredient of milk thistle extract, silybin (SIB), to treat cancers. Strong cytotoxic effects of SIB‐AgNPs against two distinct cell lines (MCF‐7 and HepG2) are observed on a stable nano‐platform that contains spherical nanoparticles within a limited size range. With a high radiochemical purity, radioiodination of SIB‐AgNPs was accomplished. The investigation on the biodistribution of [131I]iodo‐SIB‐AgNPs in mice‐bearing tumors showed that SIB‐AgNPs prefer localization in tumor tissue. In conclusion, this work strengthens the case for [131I]iodo‐SIB‐AgNPs as an effective theranostic agent for tumor imaging and treatment.
Revitalizing Itraconazole: Unleashing its Anticancer Potential through Oral Nanosystems for Liver Targeting and Biodistribution Profiling in an Animal Model using Radiolabeling Technique
Eman Abdelhakeem, Asmaa Ashraf Nemr, Hassan M. Rashed, Adli A. Selim, Basma M. Essa, et al.
Journal of Drug Delivery Science and Technology, 2025
Eco-friendly synthesis of novel enaminonitrile pyridine derivatives: 131I-radiosynthesis, anticancer investigation and in vivo study in tumour-bearing mice
Adli A. Selim, Basma M. Essa, Safaa S. Shaban, Galal H. Sayed, Marwa M. Mehany, et al.
Journal of Drug Targeting, 2025
Novel pyridine bearing pentose moiety-based anticancer agents: design, synthesis, radioiodination and bioassessments
Marwa M. Mehany, Olfat A. Hammam, Adli A. Selim, Galal H. Sayed, Kurls E. Anwer
Scientific Reports, 2024
Pyridine compounds are one of the most important heterocyclic derivatives showing wide ranges in biological and pharmacological activities. Green chemistry eliminates or reduces the generation of hazardous compounds. It prevents pollution at a molecular level. The microwave technique used in heterocyclic compound synthesis is also an important branch of green chemistry techniques. In this study, we report designing and synthesizing a new pyridine-bearing pentose moiety via a one-pot multicomponent reaction using D-glucose and also investigate its behavior and reactivity toward some simple and heterocyclic amino derivatives. The chemical structures of the synthesized compounds were characterized and tested for their cytotoxic activities. Some of the test compounds exhibited slight to high cytotoxic activities against Caco2 (colon cancer) cells, HepG2 (hepatocellular carcinoma) cells and MCF-7 (human breast cancer) cells by MTT assay. The results showed clearly that compound 4 and compound 8 displayed strongest to moderate cytotoxic activity against the HepG2, Caco2 and MCF-7 respectively and compound 1 showed good activity against MCF-7 in comparison to the standard anticancer drug doxorubicin. These data were by cytopathological examination. An in-vivo radioactive tracing study of compound 4 proved its targeting ability to sarcoma cells in a tumor-bearing mice model. Our findings suggest that the synthesized compounds may be promising candidates as novel anticancer agents.
Biogenic harmony of biocompatible silver nanoplatforms using chamomile extract and apigenin-7-glucoside for solid tumor therapy
Adli A. Selim, Islam M. Abdelmonem, Mohamed A. Amin, Basma M. Essa
Journal of Radioanalytical and Nuclear Chemistry, 2024
Intranasal Radioiodinated Ferulic Acid Polymeric Micelles as the First Nuclear Medicine Imaging Probe for ETRA Brain Receptor
Hend Fayez, Adli Selim, Rehab Shamma, Hassan Rashed
Current Radiopharmaceuticals, 2024
Green synthesis of highly functionalized heterocyclic bearing pyrazole moiety for cancer-targeted chemo/radioisotope therapy
Kurls E. Anwer, Galal H. Sayed, Basma M. Essa, Adli A. Selim
BMC Chemistry, 2023
Niosomal formulation of mefenamic acid for enhanced cancer targeting; preparation, characterization and biodistribution study using radiolabeling technique
Mona A. Shewaiter, Adli A. Selim, Hassan M. Rashed, Yasser M. Moustafa, Shadeed Gad
Journal of Cancer Research and Clinical Oncology, 2023
Cod liver oil nano-structured lipid carriers (Cod-NLCs) as a promising platform for nose to brain delivery: Preparation, in vitro optimization, ex vivo cytotoxicity & in vivo biodistribution utilizing radioiodinated zopiclone
Esraa Taha, Samia A. Nour, Wael Mamdouh, Adli A. Selim, Mohamed M. Swidan, et al.
International Journal of Pharmaceutics X, 2023
Gold Nanoparticles: Synthesis, Functionalization and Biomedical Applications Especially in Cardiovascular Therapy
Adli A. Selim, Tamer M. Sakr, Basma M. Essa
Pharmaceutical Chemistry Journal, 2023
Histopathology, pharmacokinetics and estimation of interleukin-6 levels of Moringa oleifera leaves extract-functionalized selenium nanoparticles against rats induced hepatocellular carcinoma
Eman M. M. Ebrahem, Galal H. Sayed, Gehan N. A. Gad, Kurls E. Anwer, Adli A. Selim
Cancer Nanotechnology, 2022
New 5-Aryl-1,3,4-Thiadiazole-Based Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation and In Vivo Radioactive Tracing Studies
Rana M. El-Masry, Basma M. Essa, Adli A. Selim, Soad Z. El-Emam, Khaled O. Mohamed, et al.
Pharmaceuticals, 2022
Radioiodinated acemetacin loaded niosomes as a dual anticancer therapy
Mona A. Shewaiter, Adli A. Selim, Yasser M. Moustafa, Shadeed Gad, Hassan M. Rashed
International Journal of Pharmaceutics, 2022
Anti-cancer, anti-inflammatory and antioxidant effects of Vit-A/C@SeNPs in mutual diethylnitrosamine and carbon tetrachloride induced hepatocellular damage in albino rats
Safa A. Aljuhr, Gamal Abdelaziz, Adli A. Selim, Wafaa A. Zaghary, Tamer M. Sakr
Journal of Drug Delivery Science and Technology, 2022
Conventional and microwave-assisted synthesis, anticancer evaluation, 99mTc-coupling and In-vivo study of some novel pyrazolone derivatives
Basma M. Essa, Adli A. Selim, Galal H. Sayed, Kurls E. Anwer
Bioorganic Chemistry, 2022
Lung Cancer-Targeted [131I]-Iodoshikonin as Theranostic Agent: Radiolabeling, In Vivo Pharmacokinetics and Biodistribution
Adli A. Selim, M. A. Motaleb, Hend A. Fayez
Pharmaceutical Chemistry Journal, 2022
Bone targeted new zoledronate derivative: design, synthesis, 99mTc-coupling, in-silico study and preclinical evaluation for promising osteosarcoma therapy
Hend Fayez, Adli Abdallah Selim
International Journal of Radiation Biology, 2022
Preparation and preliminary evaluation study of [131I]iodocolchicine-gallic-AuNPs: a potential scintigraphic agent for inflammation detection
Basma M. Essa, Adli A. Selim, O. A. El-Kawy, Gamal Abdelaziz
International Journal of Radiation Biology, 2022
Extraction, purification and radioiodination of Khellin as cancer theranostic agent
Adli A. Selim, Basma M. Essa, Islam M. Abdelmonem, Mohamed A. Amin, Mona O. Sarhan
Applied Radiation and Isotopes, 2021

RECENT SCHOLAR PUBLICATIONS

Design, eco-friendly synthesis, antibacterial evaluation, radiolabeling and biodistribution study of some novel enaminonitrile pyridine derivatives
KE Anwer, G Abdelaziz, BM Essa, AA Selim, AA El‐Sayed, ...
Applied Radiation and Isotopes, 112608 , 2026
2026
Ecofriendly Synthesis of New Azo Compounds as Antibacterial Agents: In Vitro Screening and Preliminary In Vivo Evaluation Using 131 I‐Radiolabeling
KE Anwer, BM Essa, AA Selim, GH Sayed, SS Shaban
Archiv der Pharmazie 359 (4), e70245 , 2026
2026
Innovative Hybrid 99mTc-Exemestane Magnesium Nanoparticles: Pioneering Dual-Mode Theranostic and Precision Tumor Targeting
AA Selim, MA Amin, MM Abouhashim, AB Ibrahim
Journal of Drug Delivery Science and Technology, 107916 , 2025
2025
Citations: 1
Eco-friendly synthesis of novel enaminonitrile pyridine derivatives: 131 I-radiosynthesis, anticancer investigation and in vivo study in tumour-bearing mice
AA Selim, BM Essa, SS Shaban, GH Sayed, MM Mehany, KE Anwer
Journal of Drug Targeting, 1-9 , 2025
2025
Actinium-225/Bismuth-213 as Potential Leaders for Targeted Alpha Therapy: Current Supply, Application Barriers, and Future Prospects
MF Nawar, AA Selim, BM Essa, AF El-Daoushy, MM Swidan, ...
Cancers 17 (18), 3055 , 2025
2025
Citations: 4
Silybin loaded Ag‐nanoparticles as a drug delivery system for solid tumor theragnosis: Extraction, radioiodination, and biodistribution study
BM Essa, IM Abdelmonem, MA Amin, AA Selim
Archiv der Pharmazie 358 (3), e2400725 , 2025
2025
Citations: 4
99m Tc-labeled benzenesulfonamide derivative-entrapped gold citrate nanoparticles as an auspicious tumour targeting
AA Selim, TM Sakr, BM Essa, GH Sayed, KE Anwer
Scientific Reports 15 (1), 4687 , 2025
2025
Citations: 5
Revitalizing itraconazole: unleashing its anticancer potential through oral nanosystems for liver targeting and biodistribution profiling in an animal model using radiolabeling …
E Abdelhakeem, AA Nemr, HM Rashed, AA Selim, BM Essa, D Hegazy
Journal of Drug Delivery Science and Technology 104, 106463 , 2025
2025
Citations: 21
Synthesis and radiolabelled evaluation of novel pyrimidine derivatives as dual α-amylase inhibitors and GIT-targeted molecular imaging probe
DA Elsayed, W Shehta, S El-Kalyoubi, A Selim, MG Assy, O Metwally, ...
RSC advances 15 (36), 29544-29559 , 2025
2025
Citations: 4
Intranasal radioiodinated ferulic acid polymeric micelles as the first nuclear medicine imaging probe for ETRA brain receptor
H Fayez, A Selim, R Shamma, H Rashed
Current Radiopharmaceuticals 17 (2), 209-217 , 2024
2024
Citations: 4
Novel pyridine bearing pentose moiety-based anticancer agents: design, synthesis, radioiodination and bioassessments
MM Mehany, OA Hammam, AA Selim, GH Sayed, KE Anwer
Scientific Reports 14 (1), 2738 , 2024
2024
Citations: 30
Biogenic harmony of biocompatible silver nanoplatforms using chamomile extract and apigenin-7-glucoside for solid tumor therapy
AA Selim, IM Abdelmonem, MA Amin, BM Essa
Journal of Radioanalytical and Nuclear Chemistry 333 (2), 705-715 , 2024
2024
Citations: 5
Niosomal formulation of mefenamic acid for enhanced cancer targeting; preparation, characterization and biodistribution study using radiolabeling technique
MA Shewaiter, AA Selim, HM Rashed, YM Moustafa, S Gad
Journal of Cancer Research and Clinical Oncology 149 (20), 18065-18080 , 2023
2023
Citations: 11
Cod liver oil nano-structured lipid carriers (Cod-NLCs) as a promising platform for nose to brain delivery: Preparation, in vitro optimization, ex vivo cytotoxicity & in vivo …
E Taha, SA Nour, W Mamdouh, AA Selim, MM Swidan, AB Ibrahim, ...
International Journal of Pharmaceutics: X 5, 100160 , 2023
2023
Citations: 48
Green synthesis of highly functionalized heterocyclic bearing pyrazole moiety for cancer-targeted chemo/radioisotope therapy
KE Anwer, GH Sayed, BM Essa, AA Selim
BMC chemistry 17 (1), 139 , 2023
2023
Citations: 16
Gold Nanoparticles: Synthesis, Functionalization and Biomedical Applications Especially in Cardiovascular Therapy
AA Selim, TM Sakr, BM Essa
Pharmaceutical Chemistry Journal 57 (1), 29-39 , 2023
2023
Citations: 10
Niosomes as a novel pharmaceutical carrier: structure, classification and preparation methods
MA Mahmoud
Records of Pharmaceutical and Biomedical Sciences 7 (3), 15-24 , 2023
2023
Citations: 8
Nanoemulsion formulation of pregabalin for enhanced nose to brain delivery and biological tracking using radiolabeling with 99mTc
H Fayez, AA Selim, RN Shamma, HM Rashed
Bulletin of Faculty of Pharmacy Cairo University 61 (1), 10 , 2023
2023
Citations: 1
New 5-aryl-1, 3, 4-thiadiazole-based anticancer agents: Design, synthesis, in vitro biological evaluation and in vivo radioactive tracing studies
RM El-Masry, BM Essa, AA Selim, SZ El-Emam, KO Mohamed, TM Sakr, ...
Pharmaceuticals 15 (12), 1476 , 2022
2022
Citations: 10
Radioiodinated acemetacin loaded niosomes as a dual anticancer therapy
MA Shewaiter, AA Selim, YM Moustafa, S Gad, HM Rashed
International Journal of Pharmaceutics 628, 122345 , 2022
2022
Citations: 20

MOST CITED SCHOLAR PUBLICATIONS

An easy and effective method for synthesis and radiolabelling of risedronate as a model for bone imaging
MA Motaleb, ASA Adli, M El‐Tawoosy, MH Sanad, M AbdAllah
Journal of Labelled Compounds and Radiopharmaceuticals 59 (4), 157-163 , 2016
2016
Citations: 58
Cod liver oil nano-structured lipid carriers (Cod-NLCs) as a promising platform for nose to brain delivery: Preparation, in vitro optimization, ex vivo cytotoxicity & in vivo …
E Taha, SA Nour, W Mamdouh, AA Selim, MM Swidan, AB Ibrahim, ...
International Journal of Pharmaceutics: X 5, 100160 , 2023
2023
Citations: 48
Novel thiobarbiturates as potent urease inhibitors with potential antibacterial activity: Design, synthesis, radiolabeling and biodistribution study
HG Abdulwahab, MF Harras, NG El Menofy, AM Hegab, BM Essa, ...
Bioorganic & Medicinal Chemistry 28 (23), 115759 , 2020
2020
Citations: 45
Synthesis, radiolabeling and biological distribution of a new dioxime derivative as a potential tumor imaging agent
MA Motaleb, AA Selim, M El-Tawoosy, MH Sanad, MA El-Hashash
Journal of Radioanalytical and Nuclear Chemistry 314 (3), 1517-1522 , 2017
2017
Citations: 45
Synergistic cytotoxicity of shikonin‐silver nanoparticles as an opportunity for lung cancer
H Fayez, MA El‐Motaleb, AA Selim
Journal of Labelled Compounds and Radiopharmaceuticals 63 (1), 25-32 , 2020
2020
Citations: 44
Synthesis, characterization, radiolabeling and biodistribution of a novel cyclohexane dioxime derivative as a potential candidate for tumor imaging
EHMA Motaleb MA, Selim AA, El-Tawoosy M, Sanad MH
International Journal of Radiation Biology , 2018
2018
Citations: 43
Dioximes: Synthesis and biomedical applications
MA Motaleb, AA Selim
Bioorganic Chemistry 82, 145-155 , 2019
2019
Citations: 40
Platelet-12 lipoxygenase targeting via a newly synthesized curcumin derivative radiolabeled with technetium-99m
RI Al-Wabli, TMMH Sakr, MA Khedr, AA Selim, MAEMA El-Rahman, ...
Chemistry Central Journal 10 (1), 73 , 2016
2016
Citations: 39
Conventional and microwave-assisted synthesis, anticancer evaluation, 99mTc-coupling and In-vivo study of some novel pyrazolone derivatives
BM Essa, AA Selim, GH Sayed, KE Anwer
Bioorganic Chemistry 125, 105846 , 2022
2022
Citations: 36
Novel pyridine bearing pentose moiety-based anticancer agents: design, synthesis, radioiodination and bioassessments
MM Mehany, OA Hammam, AA Selim, GH Sayed, KE Anwer
Scientific Reports 14 (1), 2738 , 2024
2024
Citations: 30
Synthesis, characterization, and radiolabeling of heterocyclic bisphosphonate derivative as a potential agent for bone imaging
MA Motaleb, MH Sanad, AA Selim, M El-Tawoosy, M Abd-Allah
Radiochemistry 60 (2), 201-207 , 2018
2018
Citations: 30
Histopathology, pharmacokinetics and estimation of interleukin-6 levels of Moringa oleifera leaves extract-functionalized selenium nanoparticles against rats induced …
KEAAAS Eman M. M. Ebrahem, Galal H. Sayed, Gehan N. A. Gad
Cancer Nanotechnology 13 (14) , 2022
2022
Citations: 23
Revitalizing itraconazole: unleashing its anticancer potential through oral nanosystems for liver targeting and biodistribution profiling in an animal model using radiolabeling …
E Abdelhakeem, AA Nemr, HM Rashed, AA Selim, BM Essa, D Hegazy
Journal of Drug Delivery Science and Technology 104, 106463 , 2025
2025
Citations: 21
Radioiodinated acemetacin loaded niosomes as a dual anticancer therapy
MA Shewaiter, AA Selim, YM Moustafa, S Gad, HM Rashed
International Journal of Pharmaceutics 628, 122345 , 2022
2022
Citations: 20
Extraction, purification and radioiodination of Khellin as cancer theranostic agent
AA Selim, BM Essa, IM Abdelmonem, MA Amin, MO Sarhan
Applied Radiation and Isotopes 178, 109970 , 2021
2021
Citations: 18
Green synthesis of highly functionalized heterocyclic bearing pyrazole moiety for cancer-targeted chemo/radioisotope therapy
KE Anwer, GH Sayed, BM Essa, AA Selim
BMC chemistry 17 (1), 139 , 2023
2023
Citations: 16
Anti-cancer, anti-inflammatory and antioxidant effects of Vit-A/C@ SeNPs in mutual diethylnitrosamine and carbon tetrachloride induced hepatocellular damage in albino rats
SA Aljuhr, G Abdelaziz, AA Selim, WA Zaghary, TM Sakr
Journal of Drug Delivery Science and Technology 75, 103723 , 2022
2022
Citations: 13
Lung Cancer-Targeted [ 131 I]-Iodoshikonin as Theranostic Agent: Radiolabeling, In Vivo Pharmacokinetics and Biodistribution
AA Selim, MA Motaleb, HA Fayez
Pharmaceutical Chemistry Journal 55 (11), 1163-1168 , 2022
2022
Citations: 13
Preparation and preliminary evaluation study of [ 131 I]iodocolchicine-gallic-AuNPs: a potential scintigraphic agent for inflammation detection
BM Essa, AA Selim, OA El-Kawy, G Abdelaziz
International journal of radiation biology 98 (8), 1358-1365 , 2022
2022
Citations: 12
Niosomal formulation of mefenamic acid for enhanced cancer targeting; preparation, characterization and biodistribution study using radiolabeling technique
MA Shewaiter, AA Selim, HM Rashed, YM Moustafa, S Gad
Journal of Cancer Research and Clinical Oncology 149 (20), 18065-18080 , 2023
2023
Citations: 11

Adli AbdAllah Selim

RESEARCH INTERESTS

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

MOST CITED SCHOLAR PUBLICATIONS